The objective of our study is to evaluate the impact of vaccine funding for patients seen in outpatient consultations within four healthcare institutions in the Ile-de-France region in France, made possible through the establishment of a tripartite agreement between the hospital group, the Île-de-France Regional Health Agency (ARS IDF), and the Primary Health Insurance Fund (CPAM).
Individuals aged 18 years or older,
Individuals followed in outpatient consultations within a department and healthcare institution participating in the project;
Individuals eligible for pneumococcal vaccination against according to current French recommendations,
Individuals meeting the eligibility conditions and receiving care under long-term illness coverage (ALD) or benefiting from complementary universal health coverage (C2S) or state medical aid (AME).
Individuals seen in settings other than outpatient consultations (day hospital, week hospital, conventional hospitalization, International Vaccination Center).
Assistance Publique - Hôpitaux de Paris
Lead sponsor
Agence régionale de santé Ile de France
Collaborator
Institut de Recherche en Santé Publique, France
Collaborator
URC-CIC Paris Descartes Necker Cochin
Collaborator